Drugs / PureGen Osteoprogenitor Cell Allograft
last change Nov 2013 re-read 3 minutes ago

PureGen Osteoprogenitor Cell Allograft

Cell therapy

Developed for
lumbar disk degenerative disorder
Investigated by
Alphatec Spine, Inc.

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT01294007 Feb 2011 → Nov 2013 lumbar disk degenerative disorder Alphatec Spine, Inc. Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PureGen Osteoprogenitor Cell Allograft ClinicalTrials.gov intervention name — accepted as the source's own label NCT01294007 ↗
Modality Cell therapy “PureGen Osteoprogenitor Cell Allograft” NCT01294007 ↗